215 related articles for article (PubMed ID: 36814132)
21. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).
Di Carlo V; Stiller CA; Eisemann N; Bordoni A; Matz M; Curado MP; Daubisse-Marliac L; Valkov M; Bulliard JL; Morrison D; Johnson C; Girardi F; Marcos-Gragera R; Šekerija M; Larønningen S; Sirri E; Coleman MP; Allemani C;
Br J Dermatol; 2022 Sep; 187(3):364-380. PubMed ID: 35347700
[TBL] [Abstract][Full Text] [Related]
22. The incidence of non-melanoma skin cancer in the UK and the Republic of Ireland: a systematic review.
Ibrahim N; Ali SR; Dobbs TD; Gibson JAG; Hutchings HA; Whitaker IS
Eur J Dermatol; 2023 Jun; 33(3):218-229. PubMed ID: 37594326
[TBL] [Abstract][Full Text] [Related]
23. Scrotal cancer survival is influenced by histology: a SEER study.
Johnson TV; Hsiao W; Delman KA; Canter DJ; Master VA
World J Urol; 2013 Jun; 31(3):585-90. PubMed ID: 22418823
[TBL] [Abstract][Full Text] [Related]
24. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
25. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-97.
Koh D; Wang H; Lee J; Chia KS; Lee HP; Goh CL
Br J Dermatol; 2003 Jun; 148(6):1161-6. PubMed ID: 12828744
[TBL] [Abstract][Full Text] [Related]
26. Incidence of invasive cancers following basal cell skin cancer.
Levi F; La Vecchia C; Te VC; Randimbison L; Erler G
Am J Epidemiol; 1998 Apr; 147(8):722-6. PubMed ID: 9554413
[TBL] [Abstract][Full Text] [Related]
27. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995.
Milán T; Pukkala E; Verkasalo PK; Kaprio J; Jansén CT; Koskenvuo M; Teppo L
Int J Cancer; 2000 Jul; 87(2):283-8. PubMed ID: 10861488
[TBL] [Abstract][Full Text] [Related]
28. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
[TBL] [Abstract][Full Text] [Related]
29. Incidence and trends of basal cell carcinoma in Sweden: a population-based registry study.
Kappelin J; Green AC; Ingvar Å; Ahnlide I; Nielsen K
Br J Dermatol; 2022 Jun; 186(6):963-969. PubMed ID: 34939666
[TBL] [Abstract][Full Text] [Related]
30. Nationwide Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England.
Venables ZC; Autier P; Nijsten T; Wong KF; Langan SM; Rous B; Broggio J; Harwood C; Henson K; Proby CM; Rashbass J; Leigh IM
JAMA Dermatol; 2019 Mar; 155(3):298-306. PubMed ID: 30484823
[TBL] [Abstract][Full Text] [Related]
31. [Non-melanotic Tumors of the Eyelids Skin and Inner Corner - Basocellular Carcinoma].
Furdová A; Horkovičová K; Babál P; Kobzová D; Ondrušová M
Cesk Slov Oftalmol; 2015; 71(6):293-301. PubMed ID: 26782918
[TBL] [Abstract][Full Text] [Related]
32. Rate of positive diagnosis of skin cancer and its stage in two-week wait referrals in England according to age.
Keith DJ; Jones T; Ives A; de Berker D; Verne J
Clin Exp Dermatol; 2017 Mar; 42(2):145-152. PubMed ID: 28044351
[TBL] [Abstract][Full Text] [Related]
33. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services.
Hoey SE; Devereux CE; Murray L; Catney D; Gavin A; Kumar S; Donnelly D; Dolan OM
Br J Dermatol; 2007 Jun; 156(6):1301-7. PubMed ID: 17535230
[TBL] [Abstract][Full Text] [Related]
34. Rare vulvar malignancies; incidence, treatment and survival in the Netherlands.
Pleunis N; Schuurman MS; Van Rossum MM; Bulten J; Massuger LF; De Hullu JA; Van der Aa MA
Gynecol Oncol; 2016 Sep; 142(3):440-5. PubMed ID: 27126004
[TBL] [Abstract][Full Text] [Related]
35. Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006-11.
Sella T; Goren I; Shalev V; Shapira H; Zandbank J; Rosenblum J; Kimlin MG; Chodick G
Br J Dermatol; 2015 Jan; 172(1):202-7. PubMed ID: 24976239
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of skin tumors: data from the cutaneous cancer registry in Trentino, Italy.
Boi S; Cristofolini M; Micciolo R; Polla E; Dalla Palma P
J Cutan Med Surg; 2003; 7(4):300-5. PubMed ID: 12879331
[TBL] [Abstract][Full Text] [Related]
37. Incidence and survival rates of primary cutaneous malignancies in Korea, 1999-2019: A nationwide population-based study.
Kwon SH; Choi S; Kim JS; Kim SS; Jue MS; Seo SH; Park J; Roh MR; Mun JH; Kim JY; Choi JW; Byun JW; Park S; Kim MS; Lee SJ;
J Dermatol; 2024 Apr; 51(4):532-538. PubMed ID: 38366757
[TBL] [Abstract][Full Text] [Related]
38. Problems with registration of cutaneous malignant melanoma in England.
Melia J; Frost T; Graham-Brown R; Hunter J; Marsden A; du Vivier A; Warin AP; White J; Whitehead S; Wroughton M
Br J Cancer; 1995 Jul; 72(1):224-8. PubMed ID: 7599057
[TBL] [Abstract][Full Text] [Related]
39. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe.
Mallone S; De Vries E; Guzzo M; Midena E; Verne J; Coebergh JW; Marcos-Gragera R; Ardanaz E; Martinez R; Chirlaque MD; Navarro C; Virgili G;
Eur J Cancer; 2012 May; 48(8):1167-75. PubMed ID: 22119735
[TBL] [Abstract][Full Text] [Related]
40. Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009.
Reyes E; Uribe C; de Vries E
Int J Dermatol; 2018 Jan; 57(1):21-27. PubMed ID: 29231241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
